Short Interest in H-CYTE, Inc. (OTCMKTS:HCYT) Rises By 22.7%

H-CYTE, Inc. (OTCMKTS:HCYT – Get Rating) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 5,400 shares, an increase of 22.7% from the April 30th total of 4,400 shares. Based on an average daily trading volume, of 195,300 shares, the short-interest ratio is currently 0.0 days.

OTCMKTS HCYT remained flat at $$0.02 during trading hours on Wednesday. The company had a trading volume of 2,000 shares, compared to its average volume of 87,272. H-CYTE has a fifty-two week low of $0.01 and a fifty-two week high of $0.29. The firm has a fifty day moving average of $0.02 and a 200-day moving average of $0.04.

About H-CYTE (Get Rating)

H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.

See Also

• Get a free copy of the StockNews.com research report on H-CYTE (HCYT)
• Ambarella Is A Buy For Patient Investors 
• Don’t Bet On A Big Rebound For Salesforce.com Stock 
• 3 Specialty Retailers with Special Upside
• Is Roku (NASDAQ: ROKU) Bottoming Out?
• American Well Corporation Stock May Well Be Bottoming

Want More Great Investing Ideas?